Prenatal Down's syndrome screening at 10-14 weeks gestation using the combined nuchal translucency and maternal serum biochemistry: preliminary results of the first 358 cases

R. Maymon, M. Bergman, S. Segal, E. Dreazen, Z. Weinraub, A. Herman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Prenatal Down's syndrome screening at 10-14 weeks gestation using the combined nuchal translucency and maternal serum biochemistry: preliminary results of the first 358 cases'. Together they form a unique fingerprint.

Medicine & Life Sciences